Medical News

RSS

Sebelius says HHS will not seek more money this year to implement health overhaul

"The Obama administration does not plan to seek additional money in next year's Health and Human Services Department budget to implement the new U.S. healthcare reform law, HHS Secretary Kathleen Sebelius said on Wednesday," Reuters reports. "Testifying before a House of Representatives Appropriations subcommittee, Sebelius said the $911 billion HHS budget request for fiscal year 2011, which begins Oct. 1, remains the same even after Congress passed the healthcare overhaul," which "included $1 billion" for implementation by HHS.

23 Apr 2010

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Boston Scientific Corporation today announced the launch of its new Kinetix™ Guidewire for use in percutaneous coronary intervention (PCI) procedures. Guidewires are small flexible wires physicians use to deliver interventional devices such as drug-eluting stents. The Kinetix Guidewire features a unique micro-cut nitinol sleeve designed for significantly improved torque control compared to conventional spring coil guidewires.

23 Apr 2010

Report: Wellpoint targets breast cancer patients with policy rescissions

Reuters, in an exclusive report about the insurance industry practice of rescission: "That tens of thousands of Americans lost their health insurance shortly after being diagnosed with life-threatening, expensive medical conditions has been well documented by law enforcement agencies, state regulators and a congressional committee. Insurance companies have used the practice.

23 Apr 2010

Young workers who have trouble with sleep issues more likely to quit shiftwork: Study

Working the nightshift interferes with sleep, particularly for workers in their 30s and 40s, reports a study in the April Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

23 Apr 2010

Aragon Pharmaceuticals raises $22M through Series B financing

Aragon Pharmaceuticals Inc. today announced that it has secured $22 million in Series B financing.

23 Apr 2010

Democrats, GOP continue to trade barbs over health reform, plan next moves

Politico: Democrats are following a call from President Barack Obama in daring Republicans to try to repeal the health care reform law. "And they started with what Democrats hope will become one of the most popular features of the overhaul plan, a provision that allow young adults to stay on their parents' insurance plans until age 26.

23 Apr 2010

Molecular mechanisms of hypertension, its diagnosis and treatment to be focused at ASBMB's symposium

About 1 billion people around the world suffer from hypertension. The molecular mechanisms of this disease, its diagnosis and treatment will be the focus of a lecture series at the American Society for Biochemistry and Molecular Biology's annual meeting in Anaheim, Calif. The talks will take place from Monday, May 26 through Wednesday, April 28 in room 304C of the Anaheim Convention Center.

23 Apr 2010

Acacia Research reports record first-quarter license fee revenues of $39.77M

Acacia Research Corporation today reported results for the three months ended March 31, 2010.

23 Apr 2010

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

Ampio Pharmaceuticals, Inc., today announced that it has entered into a letter of intent to acquire DMI Biosciences, Inc.

23 Apr 2010

CBO estimate: 4 million could pay health insurance penalty by 2016

The Associated Press: "Nearly 4 million Americans will have to pay a penalty if they fail to get health insurance when that element of President Barack Obama's health care overhaul law kicks in, according to congressional projections released Thursday." According to a Congressional Budget Office report, the average penalty in 2016 will be slightly more than $1,000 and the majority of people who pay the fine will be middle class.

23 Apr 2010

CRT teams up with The University of Auckland to discover novel treatments for cancer

Cancer Research Technology - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new molecular targeted compounds for the treatment of leukaemia.

23 Apr 2010

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).

23 Apr 2010

Website launched to track aid to Haiti from 'pledge to impact'

Agence France-Presse reports that the U.N. has launched "a new website to track the estimated 9.9 billion dollars in aid pledged to Haiti by the international community in the wake of a devastating January 12 earthquake." The website is a joint project of the Haitian government and the U.N. Development Programme.

23 Apr 2010

Seasonal flu vaccine causing serious side effects in under-fives: Ban on flu vaccination program

The seasonal flu vaccine has caused serious side effects in dozens of children in Western Australia (WA) and following this the Health Department has suspended further free flu vaccinations for under-fives. There has been as rise in admissions to Princess Margaret Hospital. The side effects to the flu vaccine include fever, vomiting and often seizures related to high fever, also known as febrile convulsions. One of the children is seriously ill at present.

22 Apr 2010

Zimmer reports increase of 7.1% in net sales for first-quarter

Zimmer Holdings, Inc. today reported financial results for the quarter ended March 31, 2010. The Company reported first quarter net sales of $1.06 billion, an increase of 7.1% reported and 3.4% constant currency over the first quarter of 2009. Diluted earnings per share for the quarter were $1.01 reported and $1.02 adjusted, an increase of 7.4% adjusted over the prior year period.

22 Apr 2010

AB SCIEX to collaborate in disease studies with Samuel Lunenfeld Research Institute of Mount Sinai Hospital

AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world's leading centers for biomedical research, to improve disease studies. The project is focused on better understanding cancer, diabetes and heart disease by advancing the study of proteins through the use of an emerging mass spectrometry platform currently under development by AB SCIEX.

22 Apr 2010

Karo Bio reports net loss of MSEK 40.5 for January–March 2010

KARO BIO'S PROJECTS ARE PROGRESSING

22 Apr 2010

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

Align Technology, Inc. today reported financial results for the first quarter of fiscal 2010, ended March 31, 2010.

22 Apr 2010

Codexis prices initial common stock public offering at $13.00 per share

Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."

22 Apr 2010

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Mystic Pharmaceuticals today announced it has been granted U.S. Patent 7,669,597, a key technology of its VRx2™ drug delivery platform. The VRx2™ Delivery Platform provides preservative free, precision dose delivery for ophthalmic and intranasal drugs and biologics.

22 Apr 2010

Medical News

Sebelius says HHS will not seek more money this year to implement health overhaul

Boston Scientific introduces new Kinetix Guidewire for use in PCI procedures

Report: Wellpoint targets breast cancer patients with policy rescissions

Young workers who have trouble with sleep issues more likely to quit shiftwork: Study

Aragon Pharmaceuticals raises $22M through Series B financing

Democrats, GOP continue to trade barbs over health reform, plan next moves

Molecular mechanisms of hypertension, its diagnosis and treatment to be focused at ASBMB's symposium

Acacia Research reports record first-quarter license fee revenues of $39.77M

Ampio Pharmaceuticals signs LOI to acquire DMI Biosciences

CBO estimate: 4 million could pay health insurance penalty by 2016

CRT teams up with The University of Auckland to discover novel treatments for cancer

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Website launched to track aid to Haiti from 'pledge to impact'

Seasonal flu vaccine causing serious side effects in under-fives: Ban on flu vaccination program

Zimmer reports increase of 7.1% in net sales for first-quarter

AB SCIEX to collaborate in disease studies with Samuel Lunenfeld Research Institute of Mount Sinai Hospital

Karo Bio reports net loss of MSEK 40.5 for January–March 2010

Align Technology reports 28.5% increase year-over-year in first-quarter revenues

Codexis prices initial common stock public offering at $13.00 per share

Mystic Pharmaceuticals granted U.S. patent covering VRx2 drug delivery platform technology

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News